Join
Live feed
·
INSIDERFilingvia Quantisnow
Design Therapeutics Inc. logo

Director Prasad Deepa sold $23,864 worth of shares (3,806 units at $6.27), decreasing direct ownership by 16% to 20,000 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
DSGN· Design Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DSGN (Design Therapeutics Inc.) and more on Quantisnow.